Artal Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-105,347
| Closed | -$173K | – | 20 |
|
|
2024
Q2 | $173K | Hold |
105,347
| – | – | ﹤0.01% | 106 |
|
|
2024
Q1 | $541K | Hold |
105,347
| – | – | 0.01% | 101 |
|
|
2023
Q4 | $604K | Hold |
105,347
| – | – | 0.02% | 75 |
|
|
2023
Q3 | $504K | Hold |
105,347
| – | – | 0.02% | 82 |
|
|
2023
Q2 | $448K | Hold |
105,347
| – | – | 0.01% | 99 |
|
|
2023
Q1 | $559K | Hold |
105,347
| – | – | 0.03% | 101 |
|
|
2022
Q4 | $662K | Hold |
105,347
| – | – | 0.04% | 110 |
|
|
2022
Q3 | $1.11M | Hold |
105,347
| – | – | 0.05% | 106 |
|
|
2022
Q2 | $572K | Hold |
105,347
| – | – | 0.03% | 118 |
|
|
2022
Q1 | $967K | Sell |
105,347
-300,000
| -74% | -$2.75M | 0.04% | 122 |
|
|
2021
Q4 | $6.12M | Hold |
405,347
| – | – | 0.17% | 87 |
|
|
2021
Q3 | $9.68M | Buy |
+405,347
| New | +$9.68M | 0.22% | 76 |
|